Amend Bill C-64 to remove the risks and uncertainty that would undermine the stability and affordability of Canada's drug supply.
Développement économique, Santé, Industrie, Sciences et technologies
As part of its renewed biomanufacturing strategy, the Federal Governement has announced its intentions to reinvest in this strategic sector. Sandoz Canada is interested in initiating discussions in this contexte with the potential objective of a joint investment in the life sciences sector.
Santé
Health Canada regarding regulation about Requirement for reporting of drug shortages.
Développement économique, Santé, Industrie
Health Canada regarding the Cannabis Act (C-45) for medicinal cannabis
